Keros Therapeutics

KROSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$221.073 M

$11.15 +4.70%

Close of 7 Aug 2026

Revenue

$243.9M

#2230 by revenue

Earnings

$87.0M

#1366 by earnings

Shares outstanding

19,827,188

Latest filing cover page

P/E ratio

2.5

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#258Capricor TherapeuticsCAPR$236.9M
#259Pyxis OncologyPYXS$236.3M
#260Keros TherapeuticsKROS$221.1M
#261Siga TechnologiesSIGA$218.8M
#262AN2 TherapeuticsANTX$213.6M

Where these numbers come from

Share counts and financials for Keros Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.